Steven Evan Nissen

Steven Evan Nissen's AcademicInfluence.com Rankings

Steven Evan Nissen

Philosophy

#3060

World Rank

#5032

Historical Rank

Logic

#928

World Rank

#1509

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Steven Evan Nissen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Steven Evan Nissen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. (2007) (4608)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. (2016) (2621)
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. (2004) (2339)
Alogliptin after acute coronary syndrome in patients with type 2 diabetes. (2013) (2293)
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. (2006) (1952)
American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. (2001) (1944)
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. (2003) (1747)
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5‐Year Outcomes (2017) (1559)
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. (2014) (1503)
Risk of cardiovascular events associated with selective COX-2 inhibitors. (2001) (1389)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. (2007) (1188)
Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis (2002) (1168)
Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. (1995) (1166)
ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. (1999) (1137)
Prognostic value of myeloperoxidase in patients with chest pain. (2003) (1074)
Bariatric surgery versus intensive medical therapy in obese patients with diabetes. (2012) (933)
Intravascular ultrasound: novel pathophysiological insights and current clinical applications. (2001) (855)
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. (2008) (836)
Effect of torcetrapib on the progression of coronary atherosclerosis. (2007) (773)
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. (2016) (765)
Extent and direction of arterial remodeling in stable versus unstable coronary syndromes : an intravascular ultrasound study. (2000) (764)
Effect of two intensive statin regimens on progression of coronary disease. (2011) (744)
Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial (2004) (740)
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. (2005) (740)
Intravascular Ultrasound Assessment of Lumen Size and Wall Morphology in Normal Subjects and Patients With Coronary Artery Disease (1991) (705)
High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults: Evidence From Intravascular Ultrasound (2001) (700)
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease (2005) (694)
Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. (2010) (579)
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. (2007) (573)
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus. (2005) (560)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). (2015) (560)
Risk of cardiovascular events associated with selective COX-2 inhibitors☆ (2002) (546)
Cardiovascular Efficacy and Safety of Bococizumab in High‐Risk Patients (2017) (488)
Evacetrapib and Cardiovascular Outcomes in High‐Risk Vascular Disease (2017) (462)
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. (2004) (459)
Impact of statins on serial coronary calcification during atheroma progression and regression. (2015) (443)
ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and (1999) (418)
Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial. (2011) (418)
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. (2016) (417)
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. (2008) (413)
Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. (1995) (412)
Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. (2010) (397)
Effect of ACAT inhibition on the progression of coronary atherosclerosis. (2006) (387)
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. (2016) (331)
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. (2020) (331)
Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. (2008) (322)
Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. (2009) (307)
Arterial remodeling and coronary artery disease: the concept of "dilated" versus "obstructive" coronary atherosclerosis. (2001) (300)
Application of a new phased-array ultrasound imaging catheter in the assessment of vascular dimensions. In vivo comparison to cineangiography. (1990) (300)
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. (2018) (285)
Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. (2005) (270)
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. (2014) (266)
Lipid‐Reduction Variability and Antidrug‐Antibody Formation with Bococizumab (2017) (262)
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials (2018) (248)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). (2015) (235)
Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. (2003) (228)
Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity. (2019) (226)
Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis: Insights From ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation) (2008) (215)
Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. (1994) (213)
Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation. (2020) (213)
Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing (2018) (206)
Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. (2013) (200)
ADHD drugs and cardiovascular risk. (2006) (196)
Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound. (1995) (193)
Noninvasive imaging of coronary arteries: current and future role of multi-detector row CT. (2004) (191)
Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. (2006) (191)
Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography: A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden (2008) (185)
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) (181)
Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes (2013) (179)
Non-invasive assessment of plaque morphology and remodeling in mildly stenotic coronary segments: comparison of 16-slice computed tomography and intravascular ultrasound (2003) (171)
Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial. (2011) (170)
An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). (2010) (162)
Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection (2021) (160)
Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial. (2016) (157)
Determinants of Arterial Wall Remodeling During Lipid-Lowering Therapy: Serial Intravascular Ultrasound Observations From the Reversal of Atherosclerosis With Aggressive Lipid Lowering Therapy (REVERSAL) Trial (2006) (151)
Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. (2006) (151)
Assessment of omega‐3 carboxylic acids in statin‐treated patients with high levels of triglycerides and low levels of high‐density lipoprotein cholesterol: Rationale and design of the STRENGTH trial (2018) (150)
Analyses of cancer data from three ezetimibe trials. (2009) (148)
The dilemma of diagnosing coronary calcification: angiography versus intravascular ultrasound. (1996) (148)
Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano. (2006) (146)
Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound. (2012) (146)
Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol. (2010) (144)
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN. (2014) (143)
The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. (2010) (139)
Application of intravascular ultrasound to characterize coronary artery disease and assess the progression or regression of atherosclerosis. (2002) (134)
Coronary artery calcification and changes in atheroma burden in response to established medical therapies. (2007) (134)
Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials. (2007) (129)
Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. (2005) (125)
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. (2009) (123)
Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantation: insights from systematic intravascular ultrasound imaging. (1996) (122)
Value and limitations of computer analysis of digital subtraction angiography in the assessment of coronary flow reserve. (1986) (120)
High-dose statins in acute coronary syndromes: not just lipid levels. (2004) (119)
Development of transplantation vasculopathy and progression of donor-transmitted atherosclerosis: comparison by serial intravascular ultrasound imaging. (1998) (115)
Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. (1999) (115)
Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib. (2015) (115)
-Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials (2007) (113)
C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy (2013) (109)
Effect of Serial Infusions of CER-001, a Pre-&bgr; High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial (2018) (108)
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: revascularization in diabetic patients. (2002) (105)
Non-HDL Cholesterol and Triglycerides: Implications for Coronary Atheroma Progression and Clinical Events (2016) (105)
Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruct (2011) (103)
Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes (2019) (102)
Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial (2018) (101)
Coronary angiography and intravascular ultrasound. (2001) (100)
Lumen Loss in Transplant Coronary Artery Disease Is a Biphasic Process Involving Early Intimal Thickening and Late Constrictive Remodeling Results From a 5-Year Serial Intravascular Ultrasound Study (2001) (97)
Mechanism of acute myocardial infarction in patients with prior coronary artery bypass grafting and therapeutic implications. (1990) (93)
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial (2016) (92)
Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients With Cardiogenic Shock After Acute Myocardial Infarction (2007) (91)
Peripheral arterial disease and progression of coronary atherosclerosis. (2010) (90)
Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study. (2008) (90)
The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial. (2017) (90)
Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy. (2013) (89)
ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies (2012) (87)
Coronary Plaque Morphology and Frequency of Ulceration Distant From Culprit Lesions in Patients With Unstable and Stable Presentation (2003) (87)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials (2015) (87)
Rate of progression of coronary atherosclerotic plaque in women. (2007) (83)
Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study. (2001) (82)
Impact of intravascular ultrasound in understanding transplant coronary artery disease. (1999) (82)
A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Kentucky Acute Myocardial Infarction Trial (KAMIT) Group. (1991) (81)
Effect of Evolocumab on Coronary Plaque Composition. (2018) (81)
In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis. (2003) (80)
Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study. (2014) (77)
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 1: diagnosis of stable ischemia and ischemic heart disease. (2004) (76)
Two‐year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy (2015) (76)
Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging. (2000) (76)
JPEG compression of digital echocardiographic images: impact on image quality. (1995) (76)
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. (2015) (74)
The rise and fall of rosiglitazone. (2010) (73)
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial (2017) (72)
Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. (2021) (72)
Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis. (2009) (71)
Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study). (2006) (70)
Intravascular ultrasound of the coronary arteries: current applications and future directions. (1992) (68)
Spotty calcification and plaque vulnerability in vivo: frequency-domain optical coherence tomography analysis. (2014) (68)
Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes. (2019) (67)
Factors underlying regression of coronary atheroma with potent statin therapy. (2013) (67)
Understanding coronary artery disease: tomographic imaging with intravascular ultrasound (2002) (66)
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial (2019) (63)
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial (2020) (62)
Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trial. (2013) (61)
Atheroma Progression in Hyporesponders to Statin Therapy (2015) (61)
Relationship of contractile state to ejection performance in patients with chronic aortic valve disease. (1986) (61)
Lumen Loss in Transplant Coronary Artery Disease Is a Biphasic Process Involving Early Intimal Thickening and Late Constrictive Remodeling: Results From a 5-Year Serial Intravascular Ultrasound Study (2001) (61)
Intravascular ultrasound in cardiovascular medicine. (2006) (61)
A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: a pilot study. KAMIT Study Group. (1989) (61)
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of Bempedoic acid on cardiovascular events in patients with statin intolerance. (2020) (61)
Surrogate markers for atherosclerotic disease (2005) (60)
Safety and efficacy of LY3015014, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9): a randomized, placebo-controlled Phase 2 study (2016) (60)
Limitations of computed tomography coronary angiography. (2008) (60)
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021) (60)
Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study. (2001) (60)
Pathobiology, not angiography, should guide management in acute coronary syndrome/non-ST-segment elevation myocardial infarction: the non-interventionist's perspective. (2003) (59)
Relation of matrix-metalloproteinase 3 found in coronary lesion samples retrieved by directional coronary atherectomy to intravascular ultrasound observations on coronary remodeling. (2002) (59)
Characteristics of atherosclerotic plaque distribution in coronary artery bifurcations: an intravascular ultrasound analysis (2003) (58)
Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction. (2022) (57)
Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial Flutter (2015) (57)
Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels. (2022) (56)
High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN (2014) (56)
An Updated Meta-analysis of Risk for Myocardial Infarction and Cardiovascular Mortality (2010) (56)
Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV). (2016) (55)
Effect of rimonabant on carotid intima–media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: the AUDITOR Trial (2011) (54)
Coronary imaging: angiography shows the stenosis, but IVUS, CT, and MRI show the plaque. (2003) (54)
Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy (2014) (54)
Liver Tumors and Oral Contraceptives (1975) (53)
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study) (2020) (53)
Biomarkers: Application of intravascular ultrasound in anti-atherosclerotic drug development (2006) (53)
Use of nonionic or low osmolar contrast agents in cardiovascular procedures. American College of Cardiology Cardiovascular Imaging Committee. (1993) (52)
Tracking atherosclerosis regression: a clinical tool in preventive cardiology. (2005) (52)
Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN. (2013) (51)
Influence of operator- and patient-dependent variables on the suitability of automated quantitative coronary arteriography for routine clinical use. (1992) (51)
Contrast echo washout curves from the left ventricle: application of basic principles of indicator-dilution theory and calculation of ejection fraction. (1987) (50)
Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial (2014) (50)
Antiatherosclerotic Effects of Long-Term Maximally Intensive Statin Therapy After Acute Coronary Syndrome: Insights From Study of Coronary Atheroma by Intravascular Ultrasound Effect of Rosuvastatin Versus Atorvastatin (2014) (49)
Visit-to-visit cholesterol variability correlates with coronary atheroma progression and clinical outcomes (2018) (49)
Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study. (2017) (47)
Assessment of the functional significance of coronary stenoses. Is digital angiography the answer? (1990) (47)
Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity. (2022) (47)
Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non‐remission status after bariatric surgery (2014) (47)
Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound. (2014) (47)
Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. (2005) (46)
President's page: GAP-D2B: an alliance for quality. (2006) (46)
Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial. (2006) (45)
Near-Infrared Spectroscopy Enhances Intravascular Ultrasound Assessment of Vulnerable Coronary Plaque: A Combined Pathological and In Vivo Study (2015) (45)
Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain. (2011) (45)
Catheter ablation for cardiac arrhythmias: clinical applications, personnel and facilities. American College of Cardiology Cardiovascular Technology Assessment Committee. (1994) (45)
Left main coronary atherosclerosis progression, constrictive remodeling, and clinical events. (2013) (44)
Coronary reactivity to nitroglycerin: intravascular ultrasound evidence for the importance of plaque distribution. (1995) (44)
Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin versus AtorvastatiN) (2011) (44)
Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials. (2006) (44)
Exploring coronary atherosclerosis with intravascular imaging. (2013) (44)
Coronary atherosclerosis can regress with very intensive statin therapy. (2006) (44)
Use of exercise Doppler echocardiography to evaluate cardiac drugs: effects of propranolol and verapamil on aortic blood flow velocity and acceleration. (1988) (43)
Warfarin Use Is Associated With Progressive Coronary Arterial Calcification: Insights From Serial Intravascular Ultrasound. (2017) (43)
Visit-to-Visit Blood Pressure Variability, Coronary Atheroma Progression, and Clinical Outcomes. (2019) (43)
Reforming the continuing medical education system. (2015) (43)
Cardiac angiography without cine film: erecting a "Tower of Babel" in the cardiac catheterization laboratory. American College of Cardiology Cardiac Catheterization Committee. (1994) (43)
Pharmacogenomics and clopidogrel: irrational exuberance? (2011) (43)
Three-dimensional reconstruction of the coronary artery wall by image fusion of intravascular ultrasound and bi-plane angiography (2000) (42)
Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease (2019) (42)
Standardized Definitions for Cardiovascular and Stroke Endpoint Events in Clinical Trials (2014) (42)
Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy. (2014) (42)
Cholesterol crystals associate with coronary plaque vulnerability in vivo. (2015) (41)
Sex Differences in Nonculprit Coronary Plaque Microstructures on Frequency-Domain Optical Coherence Tomography in Acute Coronary Syndromes and Stable Coronary Artery Disease (2016) (41)
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial (2017) (41)
Managing hypertension in type 2 diabetes mellitus. (2016) (40)
Coronary intravascular ultrasound: diagnostic and interventional applications. (1995) (40)
Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach (2020) (40)
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial. (2020) (40)
ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study (2018) (39)
Automated three-dimensional assessment of coronary artery anatomy with intravascular ultrasound scanning. (2003) (39)
Association of prior metabolic and bariatric surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity (2020) (39)
Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial. (2021) (39)
Is CURE a cure for acute coronary syndromes? Statistical versus clinical significance. (2002) (38)
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy. (2022) (38)
Assessment of coronary compensatory enlargement by three-dimensional intravascular ultrasound (2000) (38)
Plaque microstructures in patients with coronary artery disease who achieved very low low-density lipoprotein cholesterol levels. (2015) (38)
Rationale for a postintervention continuum of care: insights from intravascular ultrasound. (2000) (37)
Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes. (2000) (37)
Adverse cardiovascular effects of rofecoxib. (2006) (36)
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial (2018) (35)
Intravascular ultrasound assessment of the prevalence and causes of angiographic "haziness" following high-pressure coronary stenting. (1997) (35)
Endomyocardial ultrastructural findings in preeclampsia. (1991) (35)
Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials. (2009) (35)
Unilateral tuboovarian autoamputation. (1977) (34)
Atherosclerotic plaque imaging: contemporary role in preventive cardiology. (2005) (34)
Frequency-domain optical coherence tomographic analysis of plaque microstructures at nonculprit narrowings in patients receiving potent statin therapy. (2014) (34)
Concerns about reliability in the Trial to Assess Chelation Therapy (TACT). (2013) (34)
Evaluation of left ventricular contractile pattern by intravenous digital subtraction ventriculography: comparison with cineangiography and assessment of interobserver variability. (1983) (34)
Variability of area measurements obtained with different intravascular ultrasound catheter systems: Impact on clinical trials and a method for accurate calibration. (2002) (34)
Comparison of rates of progression of coronary atherosclerosis in patients with diabetes mellitus versus those with the metabolic syndrome. (2010) (34)
Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial. (2006) (34)
Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin‐Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti‐PCSK9 Antibody in Statin‐Intolerant Subjects 3 (GAUSS‐3) Trial (2016) (33)
Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN. (2017) (33)
Repeated intravascular ultrasound imaging in cardiac transplant recipients does not accelerate transplant coronary artery disease. (2003) (33)
Statin Denial: An Internet-Driven Cult With Deadly Consequences (2017) (33)
Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis (2018) (33)
Coronary arterial remodeling: From bench to bedside (2003) (33)
Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen. (2018) (32)
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis (2018) (32)
The current status of intravascular ultrasound imaging. (1999) (32)
Who is at risk for atherosclerotic disease? Lessons from intravascular ultrasound. (2002) (31)
Prediction of short- and long-term outcomes by troponin T levels in low-risk patients evaluated for acute coronary syndromes. (2000) (31)
Static and serial assessments of coronary arterial remodeling are discordant: an intravascular ultrasound analysis from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. (2006) (31)
Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long‐Term Mortality After Noncardiac Vascular Surgery (2017) (31)
Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study. (2021) (31)
Evacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients. (2016) (31)
Adults with long-duration type 2 diabetes have blunted glycemic and β-cell function improvements after bariatric surgery (2014) (31)
Etiologic factors in the pathogenesis of liver tumors associated with oral contraceptives. (1977) (31)
Left main trunk coronary artery dissection as a consequence of inaccurate coronary computed tomographic angiography. (2011) (30)
Cardiogenic shock in the setting of severe aortic stenosis: role of intra-aortic balloon pump support (2010) (30)
Coronary atherosclerotic disease burden: an emerging endpoint in progression/regression studies using intravascular ultrasound. (2003) (30)
Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus (2013) (30)
Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trial. (2017) (30)
Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review. (2021) (30)
Cardiovascular Effects of Diabetes Drugs: Emerging From the Dark Ages (2012) (29)
Intravascular ultrasound assessment of novel antiatherosclerotic therapies: rationale and design of the Acyl-CoA:Cholesterol Acyltransferase Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Study. (2006) (29)
HCAHPS Survey Results: Impact of Severity of Illness on Hospitals' Performance on HCAHPS Survey Results (2014) (29)
Effect of Bariatric Surgery Versus Intensive Medical Management on Diabetic Ophthalmic Outcomes (2015) (29)
Comparison of coronary atherosclerotic volume in patients with glomerular filtration rates < or = 60 versus > 60 ml/min/1.73 m(2): a meta-analysis of intravascular ultrasound studies. (2007) (28)
Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care (2021) (28)
Comparison of simultaneously performed digital and film-based angiography in assessment of coronary artery disease. (1988) (27)
Intracoronary ultrasound examinations reveal significantly more advanced coronary atherosclerosis in people with type 1 diabetes than in age- and sex-matched non-diabetic controls (2007) (27)
Prevalence and distribution of transplant coronary artery disease: insights from intravascular ultrasound imaging. (1995) (27)
Gastrointestinal Surgery for Obesity and Diabetes: Weight Loss and Control of Hyperglycemia (2012) (27)
Variability of area measurements obtained with different intravascular ultrasound catheter systems: Impact on clinical trials and a method for accurate calibration (2003) (26)
Association of liver tumors with oral contraceptives. (1976) (26)
Setting the RECORD Straight. (2010) (26)
Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation (2021) (26)
Role of oral contraceptive agents in the pathogenesis of liver tumors. (1979) (26)
Conflicts of Interest and Professional Medical Associations: Progress and Remaining Challenges. (2017) (26)
U.S. Dietary Guidelines: An Evidence-Free Zone (2016) (25)
Prevention guidelines: bad process, bad outcome. (2014) (25)
ETC-216 for coronary artery disease (2011) (25)
Angiotensin-receptor blockers and cancer: urgent regulatory review needed. (2010) (24)
Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes (2020) (24)
Application of intravascular ultrasound for detection and quantitation of coronary atherosclerosis (2005) (24)
Coronary intravascular ultrasound: implications for understanding the development and potential regression of atherosclerosis. (2001) (24)
Determination of left ventricular ejection fraction by computer densitometric analysis of digital subtraction angiography: experimental validation and correlation with area-length methods. (1987) (23)
Progression of coronary atherosclerosis in stable patients with ultrasonic features of high-risk plaques. (2014) (23)
Acute effects of parenteral beta-blockade on regional ventricular function of infarct and noninfarct zones after reperfusion therapy in humans. (1991) (23)
Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events. (2016) (23)
ALOGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES AFTER ACUTE CORONARY SYNDROMES: HEART FAILURE OUTCOMES AND CARDIOVASCULAR SAFETY IN HEART FAILURE PATIENTS (2014) (22)
New targets of high-density lipoprotein therapy (2007) (22)
Nonuniformity of the transmural distribution of coronary blood flow during the cardiac cycle. In vivo documentation by contrast echocardiography. (1989) (22)
Influence of aortic valve disease on systolic stiffness of the human left ventricular myocardium. (1987) (22)
Digital storage and transmission of cardiovascular images: what are the costs, benefits and timetable for conversion? (1996) (22)
American College of Cardiology/European Society of Cardiology International Study of Angiographic Data Compression Phase I: The effect of lossy data compression on recognition of diagnostic features in digital coronary angiography. (2000) (21)
Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study). (2009) (21)
The DREAM trial (2006) (21)
Prognostic value of absolute versus relative measures of the procedural result after successful coronary stenting: importance of vessel size in predicting long-term freedom from target vessel revascularization. (2001) (21)
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics (2021) (21)
The vulnerable coronary plaque. (2000) (21)
Association of arterial expansion (expansive remodeling) of bifurcation lesions determined by intravascular ultrasonography with unstable clinical presentation. (2001) (20)
Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction (2017) (20)
Mechanics of postextrasystolic potentiation in normal subjects and patients with valvular heart disease. (1986) (20)
Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin (2016) (20)
Clinical images from intravascular ultrasound: coronary disease, plaque rupture, and intervention--the inside view. (2001) (19)
American College of Cardiology/ European Society of Cardiology international study of angiographic data compression phase III. Measurement Of image quality differences at varying levels of data compression. (2000) (19)
How Much Weight Loss is Required for Cardiovascular Benefits? Insights From a Metabolic Surgery Matched-cohort Study. (2020) (19)
Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients. (2014) (19)
The ASTEROID trial: coronary plaque regression with high-dose statin therapy. (2006) (19)
Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection. (2021) (19)
The National Institute for Health and Care Excellence update for stable chest pain: poorly reasoned and risky for patients (2017) (19)
American College of Cardiology/ European Society of Cardiology international study of angiographic data compression phase I. The effects of lossy data compression on recognition of diagnostic features in digital coronary angiography. (2000) (18)
The new era of medical imaging. (2006) (18)
Task force 2: Investigator participation in clinical research. (2004) (18)
Rosiglitazone: a case of regulatory hubris (2013) (18)
Validation of an automated system for luminal and medial-adventitial border detection in three-dimensional intravascular ultrasound (2003) (17)
Success (but Unfinished) Story of Metabolic Surgery (2020) (17)
Assessing coronary plaque burden and plaque vulnerability: atherosclerosis imaging with IVUS and emerging noninvasive modalities. (2003) (17)
Early constriction or expansion of the external elastic membrane area determines the late remodeling response and cumulative lumen loss in transplant vasculopathy: an intravascular ultrasound study with 4-year follow-up. (2003) (17)
Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population. (2022) (17)
Recommendations for development and maintenance of competence in coronary interventional procedures. American College of Cardiology Cardiac Catheterization Committee. (1993) (17)
New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk (2018) (17)
Can we trust cardiovascular practice guidelines?: comment on "Conflicts of interest in cardiovascular clinical practice guidelines". (2011) (17)
Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial (2018) (17)
ADAPT: The Wrong Way to Stop a Clinical Trial (2006) (17)
Study Design and Rationale of VALOR-HCM: Evaluation of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy who are Eligible for Septal Reduction Therapy. (2021) (17)
Use of radiographic devices by cardiologists (1995) (16)
Statins in a Distorted Mirror of Media (2020) (16)
Novel Pathophysiological Insights and Current Clinical Applications (2001) (16)
Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study (2007) (16)
Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN. (2016) (16)
Relationship between residual atheroma burden and neointimal growth in patients undergoing stenting: analysis of the atherectomy before MULTI-LINK improves lumen gain and clinical outcomes trial intravascular ultrasound substudy. (2002) (15)
Shortcomings of coronary angiography and their implications in clinical practice. (1999) (15)
Incremental value of intravascular ultrasound during rotational coronary atherectomy. (1996) (15)
Cardiovascular Biomarkers After Metabolic Surgery Versus Medical Therapy for Diabetes. (2019) (15)
Preliminary Observations From Preliminary Trial Results: Have We Finally Had Enough? (2008) (15)
Determination of coronary flow reserve by digital angiography: validation of a practical method not requiring power injection or electrocardiographic gating. (1990) (15)
Plaque progression in coronary arteries with minimal luminal obstruction in intravascular ultrasound atherosclerosis trials. (2010) (15)
Liraglutide and Renal Outcomes in Type 2 Diabetes: Results of the LEADER Trial (2017) (15)
Cardiovascular outcomes in randomized trials: should time to first event for "hard" end points remain the standard approach? (2009) (15)
New Model of Automated Patient-Reported Outcomes Applied in Atrial Fibrillation (2019) (15)
Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study). (2005) (15)
New drug application 21-628, Certican (everolimus), for the proposed indication of prophylaxis of rejection in heart transplantation: report from the Cardiovascular and Renal Drugs Advisory Committee, US Food and Drug Administration, November 16, 2005, Rockville, Md. (2006) (15)
Coronary angiography for follow-up of heart transplant recipients: insights from TIMI frame count and TIMI myocardial perfusion grade. (2007) (15)
Atherosclerosis regression: Is low-density lipoprotein or high-density lipoprotein the answer? (2007) (14)
Cox-2 inhibitors and cardiovascular risk: we defend our data and suggest caution. (2001) (14)
Is the tri-layer arterial appearance an artifact? Differences between in vivoand in vitrointravascular ultrasound (1991) (14)
Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD. (2004) (14)
A Prospective, Randomized Trial Comparing Combination Half‐Dose Tissue‐Type Plasminogen Activator and Streptokinase With Full-Dose Tissue‐Type Plasminogen Activator (1991) (14)
The vulnerable plaque "hypothesis": promise, but little progress. (2009) (14)
Impact of everolimus on allograft vasculopathy the SDZ Rad/heart intravascular ultrasound study (2002) (14)
Coronary artery imaging with multidetector computed tomography: a call for an evidence-based, multidisciplinary approach. (2006) (14)
Perspective: Effect of rosiglitazone on cardiovascular outcomes (2007) (14)
Atrial fibrillation increases length of stay and cost after cardiac surgery in low risk patients targeted for early discharge (1996) (14)
Absolute, not relative, post-stent lumen area is a better predictor of clinical outcome (1996) (14)
Evolution of the filmless cardiac angiography suite: promise and perils of the evolving digital era. (1996) (14)
IVUS Made Easy (2005) (13)
Effects of Long-term Testosterone Treatment on Cardiovascular Outcomes in Men with Hypogonadism: Rationale and Design of the TRAVERSE Study (2021) (13)
Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation Study (2015) (13)
Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial (2020) (13)
Comparative Effects of Low-Dose Rosuvastatin, Placebo and Dietary Supplements on Lipids and Inflammatory Biomarkers. (2022) (13)
Cox-2 inhibitors and cardiovascular disease: considerable heat, but not much light. (2012) (13)
Statin-induced coronary artery disease regression rates differ in men and women (2015) (13)
Quantitation of aortic regurgitation by computer analysis of digital subtraction angiography. (1987) (12)
An Atlas and Manual of Coronary Intravascular Ultrasound Imaging (2003) (12)
Assessment of the severity of valvular regurgitation by digital subtraction angiography compared to cineangiography. (1985) (12)
Working group 6: The role of technology to enhance clinical and educational efficiency. (2004) (12)
Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study. (2012) (12)
The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE (2019) (12)
Influence of coronary pulsation on volumetric intravascular ultrasound measurements performed without ECG-gating. Validation in vessel segments with minimal disease. (2003) (12)
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. (2017) (12)
Assessment of vascular disease by intravascular ultrasound. (1990) (11)
The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events (2016) (11)
217 IMPACT OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITION ON NUCLEAR MAGNETIC RESONANCE DERIVED LIPOPROTEIN PARTICLE PARAMETERS (2011) (11)
Delayed Presentation of STEMI Complicated by Ventricular Septal Rupture in the Era of COVID-19 Pandemic (2020) (11)
American College of Cardiology/European Society of Cardiology International Study of Angiographic Data Compression Phase III: measurement of image quality differences at varying levels of data compression. (2000) (11)
Report from the Cardiovascular and Renal Drugs Advisory Committee: US Food and Drug Administration; June 15-16, 2005; Gaithersburg, Md. (2005) (10)
Introduction and background: the International Angiographic Compression study. (2000) (10)
Atherosclerotic plaque distribution in the left anterior descending coronary artery as assessed by intravascular ultrasound. (2003) (10)
Lessons from Coronary Intravascular Ultrasound on the Importance of Raising High-Density Lipoprotein Cholesterol (2010) (10)
Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular events. (2020) (10)
Intravascular ultrasound evidence of ostial narrowing in nonatherosclerotic left main coronary arteries. (2002) (10)
Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunities (2020) (10)
97th Meeting of the Cardiovascular and Renal Drugs Advisory Committee July 18th and 19th, 2002 (2002) (9)
SAFETY AND EFFICACY OF LY3015014, A NEW MONOCLONAL ANTIBODY TO PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) WITH AN INHERENTLY LONGER DURATION OF ACTION, IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: A RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING, PHASE 2 STUDY (2015) (9)
Oral Calcium Supplements Associate With Serial Coronary Calcification: Insights From Intravascular Ultrasound. (2020) (9)
N-acetyl-cysteine in the prevention of vascular restenosis after percutaneous balloon angioplasty. (2004) (9)
Plaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: Frequency-domain optical coherence tomography analysis (2015) (9)
Derivation and Validation of a Major Toxicity Risk Score Among Nonsteroidal Antiinflammatory Drug Users Based on Data From a Randomized Controlled Trial (2019) (9)
Never Let a Crisis Go to Waste (2020) (9)
The role of the American College of Cardiology in promoting and maintaining the delivery of quality cardiovascular care in the future. (2000) (9)
Regression of a donor atheroma after cardiac transplantation: serial observations with intravascular ultrasound. (2001) (9)
Progression of coronary atherosclerosis in patients without standard modifiable risk factors (2020) (9)
A prospective, randomized trial comparing combination half dose tPA with streptokinase to full dose tPA in acute myocardial infarction: Preliminary report (1990) (9)
Normal CK, elevated MB predicts complications in acute coronary syndromes. (2001) (9)
Application of indicator dilution principles to regional assessment of coronary flow reserve from digital angiography (1991) (9)
Intravascular ultrasonography: using imaging end points in coronary atherosclerosis trials. (2005) (9)
Effectiveness of statins in acute coronary syndromes. (2001) (8)
Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial (2020) (8)
Limitations of digital subtraction contrast echocardiography in enhancing left ventricular endocardial definition. (1987) (8)
Cine film replacement: digital archival requirements and remaining obstacles. (1998) (8)
Genome-wide Polygenic Score and Cardiovascular Outcomes with Evacetrapib in Patients with High-risk Vascular Disease: A Nested Case-control Study. (2020) (8)
High-Dose Statins in Acute Coronary Syndromes (2004) (8)
Biomarkers in cardiovascular medicine: the shame of publication bias. (2013) (8)
Lack of cardioprotective effect of naproxen. (2002) (8)
Acute Hemodynamic Effects of Sacubitril-Valsartan In Heart Failure Patients Receiving Intravenous Vasodilator and Inotropic Therapy: Acute Hemodynamic Effects of ARNI Therapy in Low Cardiac Output. (2020) (8)
Initiation of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure With Low Cardiac Output. (2019) (8)
Troponin T in elders with suspected acute coronary syndromes. (2003) (8)
Favorable Impact on LDL Particle Size in Response to Treatment With Pioglitazone is Associated With Less Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes. (2015) (8)
IVUS Virtual Histology: Unvalidated Gimmick or Useful Technique? (2016) (8)
Identifying patients at risk: novel diagnostic techniques (2004) (8)
Recurrent cerebral vascular accidents are an indication for ascending aortic endarterectomy. (1996) (8)
Serial intravascular ultrasound evaluation of remodeling in transplant CAD: influence of disease progression (1998) (8)
Vulnerable Plaque and Einstein's Definition of Insanity. (2020) (7)
Progression of coronary atherosclerosis in African-American patients. (2013) (7)
Association of Serum Lipoprotein (a) Levels and Coronary Atheroma Volume by Intravascular Ultrasound (2019) (7)
Spectrum of intravascular ultrasound findings in atherosclerosis: Wall morphology & lumen shape in CAD patients (1991) (7)
President's page: the rapid emergence of multi-modality cardiovascular imaging. (2006) (7)
Statin Intolerance: An Elusive But Morbid Disorder. (2017) (7)
Prediction of short- and long-term outcomes by troponin t levels in low-risk patients evaluated for acute coronary syndromes. (2000) (7)
Coronary Endothelium-Dependent Vasoreactivity and Atheroma Volume in Subjects With Stable, Minimal Angiographic Disease Versus Non–ST-Segment–Elevation Myocardial Infarction: An Intravascular Ultrasound Study (2013) (7)
Effect of recombinant apo A-1 milano on coronary atherosclerosis in patients with acute coronary syndromes (2004) (7)
Identification of the Metabolic Syndrome and Imaging of Subclinical Coronary Artery Disease: Early Markers of Cardiovascular Risk (2006) (7)
Technology-Assisted Self-Selection of Candidates for Nonprescription Statin Therapy. (2021) (6)
Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma—Reply (2004) (6)
Patient-reported Outcomes After Metabolic Surgery Versus Medical Therapy for Diabetes (2021) (6)
Atherosclerosis in 2010: New therapeutic insights (2011) (6)
Downstream coronary effects of drug-eluting stents. (2011) (6)
ENHANCE and ACCORD: Controversy over surrogate end points (2008) (6)
Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High‐Risk Vascular Disease Treated With Statin Therapy (2019) (6)
IVUS is redefining atherosclerotic disease. (2003) (6)
The Jupiter trial: Key findings, controversies, and implications (2009) (6)
Digital compression of echocardiographic images: is it viable? (1993) (6)
Abstract 12252: Effects of the Cholesteryl Ester Transfer Protein Inhibitor, Evacetrapib, Administered as Monotherapy or in Combination With Statins on Cholesterol Efflux and HDL Particles in Patients With Dyslipidemia (2014) (6)
After 70 Years, Metabolic Surgery Has Earned a Cardiovascular Outcome Trial. (2021) (6)
Functional imaging of coronary flow reserve (1987) (6)
The editor's roundtable: atherosclerosis regression. (2008) (6)
In vivo assesment of human coronary minimum laminil diameter with a multi-element intravascular ultrasound catheter: Comparison to quantitative cineangiography (1990) (6)
Mavacamten: a novel small molecule modulator of β-cardiac myosin for treatment of hypertrophic cardiomyopathy (2020) (6)
Cardiovascular Risk Reduction Following Metabolic and Bariatric Surgery. (2021) (6)
Coronary intravascular ultrasound in 2 children after cardiac transplantation. (1994) (6)
730-3 “Directional” Coronary Atherectomy Removes Atheroma More Effectively from Concentric than Eccentric Lesions: Intravascular Ultrasound Predictors of Lesional Success (1995) (6)
Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Vulnerable Plaque Features With Statin Therapy in Diabetic Patients With Coronary Artery Disease: Frequency-Domain Optical Coherence Tomography Analysis. (2018) (6)
Remodeling pattern within diseased coronary segments as evidenced by intravascular ultrasound. (2002) (5)
Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study (2022) (5)
Results of the GLAGOV trial (2017) (5)
Abstract 5052: Lowering of the Triglyceride/HDL Cholesterol Ratio Predicts the Benefit of Pioglitazone on Progression of Coronary Atherosclerosis in Diabetic Patients (2008) (5)
Coronary computed tomography angiography. The challenge of coronary calcium. (2012) (5)
Liver tumors and the pill: analyzing the data. (1976) (5)
Postimplant Phosphodiesterase-5 Inhibitor Use in Centrifugal Flow Left Ventricular Assist Devices. (2021) (5)
Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease (2022) (5)
Evaluation of peripheral vascular diameter and cross-sectional area with a multi-element ultrasonic imaging catheter: Correlation with quantitative angiography (1990) (5)
1P-0037 Design and methodology of a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden: The ASTEROID study (2003) (5)
Non-invasive volumetric assessment of aortic atheroma: a core laboratory validation using computed tomography angiography (2015) (5)
Coronary atherosclerosis in diabetic subjects: clinical significance, anatomic characteristics, and identification with in vivo imaging. (2004) (5)
Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial (2019) (5)
Strategies to promote HDL-C: an emerging therapeutic target. (2005) (5)
Natural history of donor-transmitted atherosclerosis in transplant patients: serial intravascular ultrasound study (1998) (5)
The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial (2018) (5)
C-REACTIVE PROTEIN LEVELS MODULATE LIPOPROTEIN(A)-ASSOCIATED CARDIOVASCULAR RISK IN OPTIMALLY-TREATED PATIENTS WITH HIGH-RISK VASCULAR DISEASE (2019) (4)
Comparison of digital and cine coronary arteriography (2005) (4)
Reduction in global and regional coronary vasomotion: A descriptor of atherosclerosis by intravascular ultrasound (1991) (4)
Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. (2018) (4)
Adverse Events Related to Muraglitazar Use in Diabetes—Reply (2006) (4)
Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks (2022) (4)
Fixed-Dose Combination (Polypill) for Cardiovascular Disease Prevention: A Meta-Analysis. (2022) (4)
Intravascular Ultrasound Imaging Following Mechanical Coronary Interventions: Theoretic Advantages and Initial Clinical Experience (1992) (4)
Characterization of coronary atherosclerotic plaques and the significance of vessel calcification (2001) (4)
Effect of Left Ventricular Conduction Delay on All-Cause and Cardiovascular Mortality (from the PRECISION Trial). (2019) (4)
Temporal Trends, Characteristics, and Citations of Retracted Articles in Cardiovascular Medicine (2021) (4)
INTRAVASCULAR ULTRASOUND EVALUATION OF THE EFFECT OF ROSUVASTATIN VERSUS ATORVASTATIN ON PROGRESSION OF CORONARY ATHEROSCLEROSIS: DESIGN OF THE SATURN STUDY (2008) (4)
Saving lives in acute ST-elevation myocardial infarction: The door-to-balloon initiative (2007) (4)
EJECTION FRACTION FROM THE COMPUTERIZED ANALYSIS OF CONTRAST ECHO WASHOUT CURVES. (1987) (4)
Assessing the effects of statins on atherosclerosis progression using intravascular ultrasound: rationale and design of the reversal study (2001) (4)
Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS. (2015) (4)
The complementary roles of imaging and 'omics' for future anti-atherosclerotic drug development. (2013) (4)
Courage under fire: What is the optimal approach to initial treatment of stable angina? (2008) (4)
Methods for Calculation of Coronary Flow Reserve by Computer Processing of Digital Angiograms (1988) (4)
Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients with Cancer. (2020) (4)
Commentary: Confidentiality of interim trial data—The emerging crisis (2015) (4)
Highlights of the year in JACC 2013. (2014) (3)
711-4 Low Plasma Homocysteine Levels Predict Reduced Atheroma Burden in Patients Undergoing Coronary Interventions: Evidence from Intravascular Ultrasound (1995) (3)
Comparing Coronary Atheroma Progression Rates and Coronary Events in the United States, Canada, Latin America, and Europe. (2016) (3)
High-pressure inflations do not insure ‘adequate’ stent deployment: Evidence from intravascular ultrasound (1996) (3)
Relation of cyclooxygenase isoenzyme expression and coronary artery remodeling. (2003) (3)
Development and application of coronary intravascular ultrasound: comparison to quantitative angiography (1993) (3)
ORAL CALCIUM SUPPLEMENTS ASSOCIATE WITH SERIAL CORONARY CALCIFICATION: INSIGHTS FROM INTRAVASCULAR ULTRASOUND (2019) (3)
Highlights of the Year in JACC 2011. (2012) (3)
Longitudinal High-Sensitivity C-Reactive Protein and Longer-Term Cardiovascular Outcomes in Optimally-Treated Patients With High-Risk Vascular Disease. (2021) (3)
[Imaging of coronary atherosclerotic plaque]. (2003) (3)
Abstract 1391: Atherogenic Dyslipidemia Predicts Accelerated Progression of Atherosclerosis in Patients with Coronary Artery Disease (2007) (3)
Cardiovascular Biomarkers after Metabolic Surgery versus Medical Therapy for Diabetes: Insights from the STAMPEDE Trial (2018) (3)
Nonstatin Therapy for Dyslipidemia. (2018) (3)
Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation Study. (2012) (3)
Highlights of the year in JACC 2012. (2013) (3)
N-3 polyunsaturated fatty acids for cardiovascular risk (2022) (2)
Does intensive statin therapy lower mortality and cardiovascular event risk in patients with acute coronary syndrome? (2005) (2)
Abstract 20401: Cardiorenal Risks of Celecoxib, Naproxen or Ibuprofen in Arthritis Patients : A Sub-Anaylsis From the PRECISION Trial (2017) (2)
U.S. Dietary Guidelines (2016) (2)
Plaque microstructures during metformin therapy in type 2 diabetic subjects with coronary artery disease: optical coherence tomography analysis. (2021) (2)
Abstract 3328: Baseline and Changes in Atheroma Volume Predict Clinical Outcome in Patients with Coronary Artery Disease: Insights from ILLUSTRATE (2007) (2)
Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High‐Risk Vascular Disease: Insights From the ACCELERATE Trial (2019) (2)
TIME STRETCHING STRATEGIES FOR OPTIMAL TEMPORAL ALIGNMENT OF IMAGE SEQUENCES OF UNEQUAL DURATION. (1987) (2)
General cardiologyAbstractsEffect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure (2005) (2)
ACE INHIBITOR USE AND MAJOR CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES TREATED WITH THE DPP-4 INHIBITOR ALOGLIPTIN (2015) (2)
EFFECTS OF AN APOLIPOPROTEIN A-1 INDUCER ON PROGRESSION OF CORONARY ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS IN PATIENTS WITH ELEVATED INFLAMMATORY MARKERS (2014) (2)
Purpura fulminans manifesting with Staphylococcus aureus endocarditis: a case report (2019) (2)
Current cardiology reports: Vision for the future (2007) (2)
Is routine automated quantitative analysis of coronary arteriography feasible? Evaluation of operator-dependent variables inherent to the technique (1990) (2)
Liver neoplasia and oral contraceptives. (1977) (2)
CLASSIFICATION OF CARDIAC STRUCTURES IN DIGITAL ANGIOGRAMS BY THE ANALYSIS OF PIXEL VARIANCE. (1987) (2)
Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial (2018) (2)
LONG-TERM MORTALITY FOLLOWING PERIOPERATIVE MYOCARDIAL INJURY IS INDEPENDENT OF MECHANISM OF TROPONIN ELEVATION (2016) (2)
The international angiographic compression study. (2000) (2)
REGRESSION OF CORONARY ATHEROMA VOLUME IN PATIENTS RECEIVING HIGH DOSE STATIN THERAPY: ANALYSIS OF THE SATURN STUDY (2012) (2)
Abstract 17400: Lipoprotein(a) is a Determinant of Residual Cardiovascular Risk in the Setting of Optimal LDL-C in Statin-Treated Patients With Atherosclerotic Cardiovascular Disease (2017) (2)
Cardiovascular events and COX-2 inhibitors. Authors' reply (2001) (2)
Pioglitazone vs Glimepiride in the PERISCOPE Trial—Reply (2008) (2)
Parametric Encoding of Coronary Arteriograms for the Evaluation of Hyperemic Reserve (1988) (2)
Habitual fish oil supplementation and the risk of incident atrial fibrillation: Findings from a large prospective longitudinal cohort study. (2022) (2)
Pravastatin and Aspirin. (2002) (2)
Highlights of the Year in JACC 2009. (2010) (2)
SEX-RELATED DIFFERENCE IN THE REGRESSION OF CORONARY ATHEROSCLEROSIS WITH THE PCSK9 INHIBITOR, EVOLOCUMAB: INSIGHTS FROM GLAGOV (2018) (2)
3911Impact of CETP inhibition with evacetrapib in patients with diabetes mellitus: results from ACCELERATE (2017) (1)
Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk-Reply. (2021) (1)
Chronic Oral Administration of Mineral Oil Compared With Corn Oil: Effects on Gut Permeability and Plasma Inflammatory and Lipid Biomarkers (2021) (1)
Rationale for cardiovascular medicine to separate from internal medicine and become an independent specialty (2008) (1)
President's page: "fix the formula" remains key issue in 2007. (2007) (1)
Development and progression of transplant vasculopathy: serial intravascular ultrasound study (1998) (1)
IMPACT OF MULTIPLE RISK FACTOR INTERVENTION ON PROGRESSION OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (2011) (1)
Letter to the editorStatistical versus clinical significance of the CURE study in acute coronary syndromes: Reply (2003) (1)
LARGER LIPID POOLS ASSOCIATE WITH FEATURES OF PLAQUE VULNERABILITY ON OPTICAL COHERENCE TOMOGRAPHY (2013) (1)
802-5 High Homocysteine Concentrations: An Independent Risk Factor for Coronary Atherosclerosis in Women (1995) (1)
Volumetric analysis of LAD-diagonal and LCX-obtuse marginal coronary bifurcations: An intravascular ultrasound study (2003) (1)
Gastrointestinal Events in Arthritis Patients at Increased Cardiovascular Risk Treated Chronically with Celecoxib, Naproxen or Ibuprofen: The Precision Randomized Controlled Trial (2017) (1)
The promise of digital cardiac angiography. (1986) (1)
Coding Errors in Survey Study. (2018) (1)
Impact of nonmeasurable borders and variation in cross-section counts on intravascular ultrasound measurement of atherosclerotic plaque volume. (2002) (1)
High-Density Lipoprotein-Targeted Therapies-Not Dead Yet-Reply. (2018) (1)
Abstract 1195: Proatherogenic Impact of the ACAT Inhibitor Pactimibe in Patients with Coronary Artery Disease and Multiple Risk Factors: Insights from the ACTIVATE study (2006) (1)
Treatment of normotensive coronary patients with amlodipine or enalapril: Effects on cardiovascular outcomes (2005) (1)
CARAT: will infusing a pre-beta high-density lipoprotein mimetic (CER-001) regress coronary atherosclerosis? (2017) (1)
Arterial remodeling and coronary plaque vulnerability: Insights from intravascular ultrasound (2001) (1)
C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOV (2020) (1)
CYP2C19 Genotype and Cardiovascular Events—Reply (2012) (1)
Abstract 17295: Cardiovascular Biomarkers and Long-term Outcomes in Patients with Type 2 Diabetes Mellitus Treated with Alogiptin vs. Placebo in the EXAMINE Trial (2014) (1)
Coronary atherosclerotic plaque progression: contributing factors in statin-treated patients (2020) (1)
Coronary Artery Disease: The View from Intravascular Ultrasound (1998) (1)
Highlights of the year in JACC 2010. (2011) (1)
"Lp(a) - an overlooked risk factor". (2023) (1)
Influence of various percutaneous coronary interventional devices on postinterventional luminal shape and plaque surface characteristics as determined by intravascular ultrasound. (2003) (1)
Late thrombosis with drug-eluting stents: Anatomy of a controversy and lessons learned (2007) (1)
RELATIONSHIP BETWEEN CORONARY MICRO- AND MACROVASCULAR MEASURES IN WOMEN WITH CHEST PAIN WITHOUT SIGNIFICANT CORONARY ARTERY DISEASE: AN ANCILLARY SUBSTUDY FROM THE NHBLI-SPONSORED WOMEN'S ISCHEMIA SYNDROME EVALUATION (WISE) (2011) (1)
Coronary Revascularization Strategies: Making Sense of Sparse, Limited-Quality Data. (2020) (1)
Abstract 17856: Effect of Aspirin on the Cardiovascular, Gastrointestinal, and Renal Safety of Celecoxib, Naproxen, or Ibuprofen (2017) (1)
Pharmacologic strategies for the prevention of atherosclerotic plaque progression (2004) (1)
HbA1c, Coronary atheroma progression and cardiovascular outcomes (2022) (1)
Steven Evan Nissen, MD: a conversation with the editor. Interview by William Clifford Roberts. (2004) (1)
President's page: American College of Cardiology fellowship: where ideals and personal responsibility intersect. (2006) (1)
Abstract 10453: Impact of Diabetes Duration on Atheroma Progression in Diabetic Patients with Coronary Artery Disease: Insights From Serial Intravascular Ultrasound (2011) (1)
Cardiorenal Risk of Celecoxib compared to Naproxen, or Ibuprofen in Arthritis Patients: Insights from the PRECISION trial. (2022) (1)
Atherosclerosis imaging in drug development (2007) (1)
ELEVATED LEVELS OF THE NEUTROPHIL TO LYMPHOCYTE RATIO PREDICTS INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN HIGH RISK PATIENTS: INSIGHTS FROM ACCELERATE (2018) (1)
Tolerability, Safety, and Hemodynamics of Sacubitril-Valsartan in Acutely Decompensated Heart Failure Patients with Cardiogenic Shock (2019) (1)
Evolocumab Added to Statins to Reduce Progression of Coronary Atherosclerosis-Reply. (2017) (1)
Strengthening the interpretability of clinical trial results by assessing the effect of informative censoring on the primary estimand in PRECISION (2020) (1)
Questions Surround Safety of Rosiglitazone (2007) (1)
EFFECT OF LONGER-TERM ADMINISTRATION OF EVOLOCUMAB IN PATIENTS WITH ANGIOGRAPHIC CORONARY ARTERY DISEASE: RESULTS OF THE GLAGOV OPEN LABELLED EXTENSION STUDY (2020) (1)
An evaluation of mavacamten for the treatment of symptomatic obstructive hypertrophic cardiomyopathy in adults (2022) (1)
AVERAGE CLINICIAN MEASURED BLOOD PRESSURE PREDICT CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES FOLLOWING ACUTE CORONARY SYNDROMES IN THE EXAMINE TRIAL (2017) (1)
Application of intravascular ultrasound imaging in understanding and guiding percutaneous therapy for atherosclerotic coronary disease. (1999) (1)
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin IntoleranceThe GAUSS-3 Randomized Clinical Trial (2016) (1)
Seeing is believing: imaging techniques to measure atherosclerosis progression (2004) (1)
Erratum. Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach. Diabetes Care 2020;43:852–859 (2020) (1)
Tim russert and sudden cardiac death after myocardial infarction (2008) (1)
A much-anticipated FDA reform bill is signed into law: Progress and compromise (2008) (1)
The US Food and Drug Administration: A dysfunctional agency in need of major reforms (2007) (1)
Health care disparities, the uninsured, and the role of cardiologists in the national debate (2007) (1)
COMPARISON OF THE SAFETY OF CELECOXIB, IBUPROFEN, AND NAPROXEN IN PATIENTS WITHOUT ESTABLISHED CARDIOVASCULAR DISEASE (2019) (1)
Invasive Imaging Modalities and Atherosclerosis: The Role of Intravascular Ultrasound (2009) (1)
Pharmacogenomics and Clopidogrel (2017) (1)
Characteristics of plaque microstructures in diabetic patients receiving metformin: frequency domain optical coherence tomography analysis (2015) (1)
Can We Trust the Independence of Cardiovascular Guidelines? (2019) (1)
Coronary arteriography in the intact rabbit: demonstration of coronary vasomotor and electrocardiographic effects of ergonovine and indomethacin in rabbits after abrupt cessation of prolonged nitroglycerin treatment. (1987) (1)
Limitation of intravascular ultrasound in determining artery size: role of distension pressure (2002) (1)
GREATER LIKELIHOOD OF REGRESSION OF CORONARY ATHEROSCLEROSIS WITH THE PCSK9 INHIBITOR, EVOLOCUMAB, IN PATIENTS WITH HIGHER LP(A) LEVELS (2018) (1)
Abstract 13442: Aging, Risk Factors and Progression of Coronary Atherosclerosis (2010) (1)
SAFETY OF ORAL DOFETILIDE LOADING FOR RHYTHM CONTROL OF ATRIAL ARRHYTHMIAS (2014) (1)
Impact of an electronic medical record-based appointment order on outpatient cardiology follow-up after hospital discharge (2021) (1)
Determinants of Plaque Progression Despite Very Low Low-Density Lipoprotein–Cholesterol Levels With the PCSK9 Inhibitor, Evolocumab (2021) (1)
Abstract 11186: Downstream Coronary Effects of Drug Eluting Stents: A Propensity Matched Analysis (2010) (1)
Randomized Trial Needed to Confirm Whether Dalcetrapib Improves Outcomes for Specific ADCY9 Genotype-Reply. (2018) (1)
Trial finds intensive lipid-lowering reduces coronary atherosclerosis progression more than moderate regimen. (2004) (1)
High-dose statins and atherosclerosis regression. Author's reply (2006) (1)
Negative remodeling frequently occurs in mildly stenotic native coronary lesions and is unrelated to plaque size (2002) (1)
Quality of Life Following Initial Treatment of Atrial Fibrillation with Cryoablation Versus Drug Therapy Initial Treatment with Cryoablation or Drug Therapy. (2021) (1)
Coronary Atheroma Regression With Evolocumab in Stable and Unstable Coronary Syndromes. (2022) (1)
REGRESSION OF CORONARY ATHEROSCLEROSIS IN DIABETIC PATIENTS WITH HIGH INTESITY STATIN REGIMENS: INSIGHTS FROM SATURN (2013) (0)
President's page: valvular heart disease: the convergence of interventional and surgical approaches. (2006) (0)
AGGRESSIVE USE OF ANTI-ATHEROSCLEROTIC THERAPIES SLOWS PROGRESSION OF CORONARY ATHEROMA IN PATIENTS WITH A HISTORY OF CORONARY REVASCULARIZATION (2010) (0)
Live tumors and oral contraceptives. (1977) (0)
Intravascular Ultrasound Insights into Unstable Plaques(Visualization of Vulnerable Plaque (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
MILANO-PILOT: will infusing HDL mimetics containing apoA-imilano continue to regress coronary atherosclerosis in the modern era of intensive statin therapy? (2017) (0)
Intravascular ultrasound evidence for balloon oversizing in diabetics: A factor in higher complication rates? (1996) (0)
Erratum to "C-Reactive Protein Levels and Plaque Regression with Evolocumab: Insights From GLAGOV" [American Journal of Preventive Cardiology 3C (2020) 100091]. (2021) (0)
Effect of coronary risk factors on plaque morphology: Intravascular ultrasound evidence of differing patterns (1996) (0)
Abstract 21363: Improving Glycemic Control is Associated with A Beneficial Impact on Progression of Coronary Atherosclerosis: Insights From Intravascular Ultrasound (2010) (0)
ATHEROGENIC LIPOPROTEIN VARIABILITY CORRELATES WITH CORONARY ATHEROMA PROGRESSION: INSIGHTS FROM SERIAL INTRAVASCULAR ULTRASONOGRAPHY (2017) (0)
Heterogieneity of reperfusion after reversible regional myooardial ischemia in a canine model (1993) (0)
Changing Continuing Medical Education--Reply. (2015) (0)
President's page: acute coronary care: the yardstick of value. (2006) (0)
β-Blockers and Progression of Coronary Atherosclerosis (2008) (0)
Abstract 4149: Regression of Coronary Atherosclerosis Following Intensive Risk Factor Modification in Patients With the Metabolic Syndrome (2006) (0)
Abstract 20126: CRP, Risk Factors and Major Adverse Cardiovascular Events: Insights From ACCELERATE (2017) (0)
Effect of individual high-intensity statin agents on optical coherence tomography derived measures of plaque stability (2015) (0)
The Proactive Management of “Relationship With Industry” by ACC/AHA in the Creation of Our Cardiovascular Clinical Practice Guidelines—Reply (2011) (0)
918-21 Intravascular Ultrasound Evidence of Significant Oversizing of Angioplasty Balloons in Female Patients (1995) (0)
Bias in electronic health record‐based studies: Seeing the forest for the trees (2021) (0)
VALVUIAR HEART DISEASE Influence of aortic valve disease on systolic stiffness of the human left ventricular myocardium (0)
High-Dose Statins and Atherosclerosis Regression—Reply (2006) (0)
CRYOABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY AS INITIAL TREATMENT FOR ATRIAL FIBRILLATION: IMPACT ON QUALITY OF LIFE (2021) (0)
Abstract 15937: Abnormal Left Ventricular Conduction is Associated With Increased Cardiovascular Mortality Compared to Abnormal Right Ventricular or Normal Conduction: Insights From the Precision Trial (2017) (0)
The role of the American College of Cardiology in promoting and maintaining the delivery of quality cardiovascular care in the future. (2000) (0)
The Unstable Plaque: Implications and Opportunities for Prevention (2000) (0)
Therapy with the thyroid hormone receptor agonist eprotirome in patients with familial hypercholesterolemia: a randomised, double blind, placebo-controlled study (2014) (0)
THERAPY WITH THE THYROID HORMONE RECEPTOR AGONIST EPROTIROME IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS OF THE AKKA TRIAL (2014) (0)
BLOOD PRESSURE CONTROL AND ATHEROMA PROGRESSION IN DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE: INSIGHTS FROM INTRAVASCULAR ULTRASOUND (2012) (0)
FACTORS INFLUENCING THE NATURAL HISTORY OF CORONARY ATHEROMA CALCIFICATION: INSIGHTS FROM SERIAL INTRAVASCULAR ULTRASOUND (2010) (0)
ARTERIAL WALL REMODELING IN ASSOCIATION WITH ABDOMINAL OBESITY, ADIPOCYTOKINES AND PROGRESSION OF CORONARY ATHEROSCLEROSIS: INSIGHTS FROM THE STRADIVARIUS STUDY (2010) (0)
IVUS Image Interpretation and Measurements (1996) (0)
0SOA02-2 Seeing is believing: Imaging techniques to measure atherosclerosis progression (2003) (0)
Emerging pharmacological strategies for the prevention of atherosclerotic disease progression. (2005) (0)
Abstract: P1386 LOWERING OF HBAIC IS ASSOCIATED WITH LESS PROGRESSION OF CORONARY ATHEROSCLEROSIS (2009) (0)
Normal arterial anatomy by IVUS (2005) (0)
Tu-S11:3 How far should we reduce plasma LDL-cholesterol level in high risk patients? Insights from intravascular ultrasound studies (2006) (0)
Does Body Adiposity Better Predict Obesity-Associated Cardiometabolic Risk Than Body Mass Index? (0)
Rimonabant and progression of atherosclerosis in obese persons - Reply (2008) (0)
CHAPTER 34 – Invasive Imaging Modalities and Atherosclerosis: The Role of Intravascular Ultrasound (2009) (0)
Effects of Normal, Pre-Hypertensive, and Hypertensive Blood Pressure Levels on Progression of Coronary: Reply (2007) (0)
Even low positive Troponin T values identify patients at risk for late events in suspected coronary syndromes (1998) (0)
Imaging of High-Risk Atherosclerotic Plaque by Intravascular Ultrasound: Focal Assessment of Morphology and Vulnerability or Systemic Assessment of Disease Burden and Activity? (2004) (0)
Pioglitazone vs Glimepiride in the PERISCOPE Trial. Authors' reply (2008) (0)
ApoA-1 milano and regression of atherosclerosis. Author's reply (2004) (0)
Abstract 4106: Effect of Obesity on Progression of Coronary Atherosclerosis: Observations from Four Intravascular Ultrasound Trials (2006) (0)
O040 Changes in plaque composition with a novel apolipoprotein A-I inducer: insights from the assure study (2014) (0)
High-Dose Statins in Acute Coronary Syndromes—Reply (2005) (0)
Plaque Vulnerability (Insights from Intravascular Ultrasound, Optical Coherence Tomography and Thermography) (2004) (0)
QUADRATIC MODEL TO ESTIMATE THE DOSES CAUSING THE HIGHEST CHOLESTEROL CONCENTRATION AND THE SAME CHOLESTEROL CONCENTRATION AS CONTROL GROUP (2003) (0)
TCT-245 Impact of Statin Therapy on Plaque Microstructures on Optical Coherence Tomography (2012) (0)
484 Effect of Longer-Term Administration of Evolocumab in Patients With Angiographic Coronary Artery Disease: Results of the GLAGOV Open Label Extension Study (2020) (0)
How a New Understanding of Drug or Drug Class Pharmacology Often Drives Drug Development: A Conversation with Steven E. Nissen, MD (2022) (0)
GENDER SPECIFIC FACTORS ASSOCIATED WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS: INSIGHTS FROM ACCELERATE (2018) (0)
L4 BASELINE CHARACTERISTICS OF PATIENTS IN THE SATURN STUDY, A COMPARISON OF ROSUVASTATIN VERSUS ATORVASTATIN ON CORONARY ATHEROSCLEROTIC DISEASE BURDEN (2010) (0)
Abstract 2886: Angiotesin-Converting Enzyme Inhibitors Attenuate Age-related Progression of Cardiac Allograft Vasculopathy - A Serial Volumetric Intravascular Ultrasound Study (2007) (0)
IS146 A Preoccupation With Coronary Luminology : The Dissociation Between Clinical And Angiographic Findings In Ischemic Heart Disease (1997) (0)
ATRIAL FIBRILLATION INCIDENCE, PREVALENCE, AND RISK FACTORS IN THE PRECISION TRIAL: A COHORT STUDY (2019) (0)
President's page: Keeping a commitment to our patients, our profession, and a city. (2006) (0)
Abstract 15543: Geographic Variations of Coronary Atheroma Progression and Clinical Events in Patients With Coronary Artery Disease (CAD) (2013) (0)
Hemodynamic effects of verapamil in left ventricular valvular volume overload (1985) (0)
Abstract 475: Relationship Between Oxidized Phospholipid Content On Apolipoprotein B-100 Particles, Statin Therapy and Atheroma Volume: Observations From The REVERSAL Study (2007) (0)
Reduction of Adverse Events with Phosphodiesterase 5 Inhibitors post LVAD Implantation: It is time for a Randomized Trial? (2022) (0)
OPTICAL COHERENCE TOMOGRAPHY DERIVED MEASURES OF PLAQUE VULNERABILITY IN OBESE PATIENTS WITH CORONARY ARTERY DISEASE (2014) (0)
784-4 Older Donor Age Predicts Increased Risk for Coronary Vasculopathy in the Year Following Transplantation: Serial Examination by Intravascular Ultrasound (1995) (0)
Image analysis of atherosclerotic plaque by intravascular ultrasound: correlation with clinical presentation (1998) (0)
HbA1c, coronary atheroma progression and cardiovascular events (2021) (0)
O099 Impact of High-dose Statins on Plaque Microstructures in Stable Patients with Coronary Artery Disease: Frequency-Domain Optical Coherence Tomography Analysis (2014) (0)
Abstract 17446: Fasting Remnant Cholesterol Levels Predict Incident Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease: The ACCELERATE Trial (2017) (0)
Cine film replacement: Application of real-time digital cassette tape to coronary arteriography (1990) (0)
W16-P-060 Design of a study comparing torcetrapib/atorvastatin with atorvastatin alone on atheroma volume in patients with coronary heart disease (2005) (0)
In Reply [4] (2006) (0)
Cerebral Blood Flow, Endothelial Function In Patients With Coronary Artery Disease And Arterial Hypertension Receiving Ivabradine In Combination With Perindopril (2014) (0)
PRIOR CORONARY ARTERY BYPASS GRAFTING AND INCIDENT CARDIOVASCULAR EVENTS IN THE SETTING OF CONTEMPORARY MEDICAL THERAPY: INSIGHTS FROM ACCELERATE (2018) (0)
Abstract 20260: Impact of Glycemic Control on Residual Cardiovascular Risk in Diabetic Patients Treated With Statin Therapy (2017) (0)
Abstract 15752: Incidence of Silent Myocardial Infarction in a Major Cardiovascular Clinical Trial: Insights From the PRECISION Trial (2017) (0)
Abstract 15319: N-Terminal-pro-Brain Natriuretic Peptide Decreases Following Treatment with Alogliptin in Patients with Type 2 Diabetes and Recent Acute Coronary Syndromes: Results from EXAMINE (2014) (0)
The Association Between Cholesterol Crystal And Features Of Plaque Vulnerability On Optical Coherence Tomography (2016) (0)
Anandamide as a Marker of Human Disease TotheEditor:IntheirResearchLetter,DrHabayebandcol- (2017) (0)
Lower Blood Pressure Targets: How Low Is Too Low? (2020) (0)
The Effects of Bariatric Surgery and Intensive Medical Therapy on Diabetic Retinopathy - 2 Year Data (2014) (0)
Blood pressure levels on progression of coronary atherosclerosis. Authors' reply (2007) (0)
Intravascular Ultrasound Plaque Characterization: Spectral Analysis and Tissue Maps (2003) (0)
Reperfusion therapy improves infarct zone wall motion in inferior as well as anterior wall MI (1991) (0)
Abstract 3269: Does The Metabolic Syndrome Promote Progression of Coronary Atherosclerosis Beyond The Impact of its Component Risk Factors? Observations From Intravascular Ultrasound (2008) (0)
American College of Cardiology/ European Society of Cardiology international study of angiographic data compression phase III (2016) (0)
Response to Comment On Aminian et al. Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care. Diabetes Care 2021;44:2552-2563. (2022) (0)
Abstract 17125: Predictors of Residual Plaque Progression Despite Achieving Low Levels of LDL-C With the PCSK9 Inhibitor, Evolocumab (2017) (0)
Abstract 13297: Temporal Changes in Management of Heart Transplant Recipients and Impact on Coronary Allograft Vasculopathy (2012) (0)
Antihypertensive Agents and Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure—Reply (2005) (0)
Atheroma distribution at coronary bifurcations: Impact of side branch angulation: An intravascular ultrasound study (2003) (0)
Abstract 14775: Differential Responses of Atheroma Progression to Blood Pressure Lowering in Patients with and without Diabetes (2014) (0)
196 INCREASING CIRCULATING CONCENTRATION OF ALL HDL PARTICLE SUBCLASSES IN HYPER-RESPONDERS TO APOLIPOPROTEIN A-I INDUCTION: INSIGHTS FROM THE ASSERT STUDY (2011) (0)
TCT-281 The Association Between Cholesterol Crystal And Features Of Plaque Vulnerability On Optical Coherence Tomography (2012) (0)
Quantification of coronary atherosclerosis for cardiovascular risk assessment: the hole in the doughnut? (2006) (0)
β-Blockers and Progression of Coronary Atherosclerosis. Authors' reply (2008) (0)
Using troponin T to diagnose acute coronary syndromes. (2000) (0)
LEVELS OF NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL DO NOT NEGATIVELY IMPACT THE ABILITY OF THE PCSK9 INHIBITOR, EVOLOCUMAB, TO PROMOTE REGRESSION OF CORONARY ATHEROSCLEROSIS (2018) (0)
A much-anticipated FDA reform bill is signed into law: Progress and compromise (2008) (0)
Physiological heterogeneity of coronary blood flow in space and time by contrast echocardiography (1991) (0)
Late-breaking trials at the ACC scientific sessions: Insights and controversy (2008) (0)
Abstract 1021: High Cholesteryl Ester Transfer Protein Mass Predicts Accelerated Progression of Coronary Atherosclerosis in Abdominally Obese Patients (2009) (0)
Spotty Calcification Associates with Coronary Plaque Microstructures In Vivo: Insights From Fourier-Domain Optical Coherence Tomography Analysis (2013) (0)
High-dose statins in acute coronary syndromes [1] (multiple letters) (2005) (0)
Abstract 10439: Natural History of Echolucent Plaque in Stable Patients with Coronary Artery Disease: Insights From Intravascular Ultrasound (2011) (0)
Compensatory remodeling in early coronary artery disease - a volumetric IVUS analysis (2002) (0)
President's page: the ACC's international mission: learning, leading, and sharing. (2007) (0)
Primary and secondary prevention of atherosclerotic cardiovascular disease: A case-based approach (2022) (0)
a traditional glitazone may be of concern and warrant fur- ther investigation. (2017) (0)
Imaging and peroxisome proliferator‐activated receptor agonists: Uncovering their role in atherosclerosis development (2004) (0)
American College of Cardiology/European Society of Cardiology Joint Symposium on Lipids (2008) (0)
Cost analysis of amlodipine versus enalapril in patients with coronary artery disease and normal blood pressure: findings from the CAMELOT economic substudy. (2008) (0)
Abstract 20280: Impact of the Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib on Cholesterol Efflux Capacity in High Risk Patients Within the ACCELERATE Trial (2016) (0)
Cost analysis of amlodipine versus enalapril in patients with coronary artery disease and normal blood pressure (2008) (0)
Abstract 3727: Progression of Coronary Atherosclerosis: Do ACE Inhibitors Make a Difference? (2006) (0)
GREATER PROGRESSION OF CORONARY ATHEROSCLEROSIS IN AFRICAN-AMERICAN PATIENTS DESPITE THE USE OF ESTABLISHED MEDICAL THERAPIES (2011) (0)
Abstract 3724: Optimal Control of Both Lipids and Blood Pressure is Required for Maximal Regression of Coronary Atherosclerosis (2006) (0)
The Unstable Plaque (2006) (0)
Intravascular Ultrasound: Equipment, Technique and Applications in Clinical Practice and Research (1997) (0)
Analytical Issues Regarding Rosiglitazone Meta-analysis—Reply (2011) (0)
DOSE ESCALATION AND THE SAFETY OF CELECOXIB, IBUPROFEN, AND NAPROXEN: ANALYSIS OF THE PRECISION TRIAL (2018) (0)
Terrestrial Cardiovascular Coronary Artery Disease (CAD) Screening, Treatment and Risk Mitigation - Lessons Learned from Space Medicine (2018) (0)
Intracoronary Ultrasound in Assessing Efficacy of Cardiovascular Drugs (2010) (0)
Abstract 3779: Arterial Wall Remodeling in Response to Atheroma Regression with Very Intensive Lipid Lowering: Insights from the ASTEROID Trial (2006) (0)
Abstract 3723: Pattern Of Arterial Remodeling In Association With Halting Progression Of Coronary Atherosclerosis With Pioglitazone In Diabetic Patients: Insights From The Periscope Study (2008) (0)
A Novel Deep Learning Approach for Automated Diagnosis of Acute Ischemic Infarction on Computed Tomography (2018) (0)
Abstract 16193: Greater Benefit of Anti-Atherosclerotic Therapies in Patients with A Recent Acute Coronary Syndrome (2010) (0)
ATRIAL FIBRILLATION IS NOT ASSOCIATED WITH INCREASED PROGRESSION OF CORONARY ATHEROSCLEROSIS: INSIGHTS FROM INTRAVASCULAR ULTRASOUND ATHEROSCLEROSIS TRIALS (2010) (0)
Influence of Coronary Pulsation on Volumetric Measurements Performed Using Intravascular Ultrasound (2002) (0)
A101 Individualized Diabetes Complications Risk Scores: Future Risk of Diabetes End-Organ Complications with and without Metabolic Surgery (2019) (0)
Principle of IVUS imaging (2005) (0)
Do interventionalists undersize devices during acute infarct intervention? Comparison of angiographic and intravascular ultrasound measures from the PAMI stent randomized trial (1999) (0)
IMPACT OF STATIN THERAPY ON PLAQUE MICROSTRUCTURES ON OPTICAL COHERENCE TOMOGRAPHY (2016) (0)
President's Page: John C. (Jack) Lewin, MD: From Rural Maui to CEO of the American College of Cardiology (2006) (0)
C-REACTIVE PROTEIN VARIABILITY AND CARDIOVASCULAR OUTCOMES IN OPTIMALLY-TREATED HIGH-RISK VASCULAR DISEASE (2020) (0)
Does computer-based edge enhancement alter the interpretation of digital coronary arteriograms? (1990) (0)
176 ANTI-INFLAMMATORY EFFECTS OF A NOVEL INDUCER OF APOLIPOPROTEIN A-I SYNTHESIS: INSIGHTS FROM THE ASSERT STUDY (2011) (0)
1015-72 Elevated Plasma Homocysteine: An Important Independent Risk Factor for Coronary Artery Disease in the Elderly (1995) (0)
Most Asymptomatic Diabetic Patients Will Not Benefit From Coronary Revascularization (2006) (0)
Abstract 13108: Intensive Multi-target Lipid Lowering and Progression of Coronary Atherosclerosis (2010) (0)
Burden Measured by Intravascular Ultrasound Relationship Between Cardiovascular Risk Factors and Atherosclerotic Disease (2011) (0)
Unmet needs in the treatment of hypertrophic cardiomyopathy. (2021) (0)
Report From the Cardiovascular and Renal Drugs Advisory Committee Day Class Labeling for Antihypertensive Drugs (2005) (0)
CLINICAL PREDICTORS OF CARDIOVASCULAR OUTCOMES IN PATIENTS ON CELECOXIB, IBUPROFEN, AND NAPROXEN (2019) (0)
Comprar IVUS Made Easy DVD | Steven E. Nissen | 9781841846507 | Informa Healthcare (2008) (0)
Pioglitazone May Be Effective in Reducing Progression of Atherosclerosis in Patients with Diabetes (2008) (0)
Abstract 3726: Beta-Blockers and Progression of Coronary Atherosclerosis:A Meta-Analysis from Four Intravascular Ultrasound Trials (2006) (0)
Abstract 13095: Regression of Left Main Coronary Arterial Atherosclerosis: Implications for Major Adverse Cardiovascular Events (2011) (0)
Intensive lipid lowering in the cardiovascular patient: Who, how low, and for how long? (2007) (0)
Importance of Internal Variability in Clinical Trials of Cardiovascular Disease. (2021) (0)
Abstract 11279: The Impact of Intensive LDL-C Lowering Therapy on Vulnerable Plaque Microstructures: Frequency Domain Optical Coherence Tomography Analysis (2013) (0)
Abstract 10446: Accelerated Progression of Coronary Atherosclerosis in Hyporesponders to Statin Therapy (2011) (0)
Abstract: 1495 ATHEROSCLEROTIC PROGRESSION AND REMODELING IN ARTERIES WITH MINIMAL ANGIOGRAPHIC DISEASE (2009) (0)
Coronary intravascular ultrasound: rationale, technology, and initial clinical applications (1993) (0)
Abstract 19510: Regression of Coronary Atherosclerosis With the PCSK9 Inhibitor Evolocumab in Patients With Coronary Artery Disease and Diabetes (2017) (0)
THE EFFECT OF HIGH–INTENSITY STATIN THERAPY ON CHANGES IN ATHEROMA COMPOSITION: INSIGHTS FROM SATURN (2013) (0)
Abstract 12775: The Impact of Spotty Calcification on Microstructures Within Thin-cap Fibroatheromas: Frequency Domain Optical Coherence Tomography Analysis (2013) (0)
Angiographic ‘haziness’ following stent deployment: Differential diagnosis using intravascular ultrasound (1996) (0)
Abstract 1460: Clinical Predictors of Atherosclerosis Progression in Patients With Very Low Levels of LDL Cholesterol (2009) (0)
Intravascular Ultrasound (IVUS)-Guided Treatment of in-Stent Restenosis: When Should the Interventionalist Consider Vessel Size Rather Than lumen size alone? (2004) (0)
DOWNSTREAM CORONARY EFFECTS OF DRUG ELUTING STENTS: UNINTENDED THERAPEUTIC TARGET? (2010) (0)
ACS : Insights from IVUS Imaging(State-of-the-Art)(Plenary Session 1 (PL1) (IHD) : ACS : Prevention to Treatment)(Special Program) (2004) (0)
Best Practice & Research Clinical Endocrinology & Metabolism (2016) (0)
Performance measures and outcomes for patients hospitalized with heart failure. (2007) (0)
The Impact of Plaque Attenuation and Echogenicity on Clinical Outcome: Insight from Intravascular Ultrasound (2018) (0)
20. Major Cardiovascular Outcomes in the EXAMINE Trial According to ACE Inhibitor Use (12-OR) (2015) (0)
Emerging technologies in coronary artery disease assessment: insights provided by intravascular ultrasound. (2002) (0)
Abstract 1992: Evolution of the Pattern of Atherosclerosis Assessed by Intravascular Ultrasound in Women: A Substudy of the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) (2006) (0)
Ultrasound evidence of comparable lesion severity at proximal and distal sites in transplant coronary disease (1998) (0)
Transitioning to active-controlled trials to evaluate cardiovascular safety and efficacy of medications for type 2 diabetes (2022) (0)
DRIVERS OF PROGRESSION OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2010) (0)
President's page: a new home for the American College of Cardiology. (2006) (0)
Rosiglitazone associated with increased risk of MI and cardiovascular- related death (2007) (0)
Abstract 16218: Long-Term Anti-Atherosclerotic Effects of Maximally Intensive Statin Therapy Following Acute Coronary Syndrome: Insights From SATURN (2013) (0)
Repeated intravascular ultrasound imaging in cardiac transplant recipients does not accelerate allograft vasculopathy (2001) (0)
Statins and regression of coronary atherosclerosis. Authors' reply (2007) (0)
C-reactive protein as a potential therapeutic target in patients with coronary artery disease (2005) (0)
Comparison of CKMB and troponin T in stratifying risk for adverse outcomes in a chest pain observation unit (1998) (0)
Detection of Vulnerable Coronary Plaque; The Emerging Role of Intravascular Ultrasound (2003) (0)
ApoA-1 Milano and Regression of Atherosclerosis [1] (multiple letters) (2004) (0)
The role of troponin T as an alternative to CKMB in the management of acute coronary syndromes (1998) (0)
The Acute Hemodynamic Unloading Effects of Angiotensin Receptor-Neprilysin Inhibition in Patients Receiving Intravenous Vasoactive Therapy (2020) (0)
High-dose statins in acute coronary syndromes. Authors' replies (2005) (0)
Severity of the worst lesion correlates with total plaque burden in a coronary artery: in vivo analysis in patients with mild, moderate, and severe atherosclerosis (2002) (0)
ACHIEVED LIPOPROTEIN LEVELS AND REGRESSION OF CORONARY ATHEROSCLEROSIS WITH HIGH DOSE STATIN THERAPY: INSIGHTS FROM SATURN (2012) (0)
IVUS Made Easy DVD (2008) (0)
ELEVATED CRP LEVELS DO NOT ADVERSELY MODULATE THE ABILITY OF EVOLOCUMAB TO REGRESS CORONARY ATHEROSCLEROSIS: INSIGHTS FROM GLAGOV (2018) (0)
BENEFICIAL EFFECTS OF RAISING HIGH-DENSITY LIPOPROTEIN CHOLESTEROL DEPENDS ON LEVELS OF ATHEROGENIC LIPIDS: IMPLICATIONS FOR DISEASE PROGRESSION AND CLINICAL EVENTS (2014) (0)
Error in Results and Figures 1, 2, and 3. (2018) (0)
Is Digital Angiography the Answer? (2005) (0)
Abstract 17525: Warfarin Promotes Progressive Coronary Arterial Calcification: Insights From Serial Intravascular Ultrasound (2015) (0)
Intravascular ultrasound plaque characterization via spectral analysis (2002) (0)
Are dietary supplements beneficial in lowering cholesterol? SPORT reflections and the path forward. (2022) (0)
Abstract 13340: Crp Lowering with High-Intensity Statin Therapy Associates with Regression of Coronary Atherosclerosis and Improved Clinical Outcomes: Insights from Saturn (2012) (0)
Abstract 3211: Diabetes is Associated with Greater Progression of Coronary Atherosclerosis than the Metabolic Syndrome: Insights from Serial Intravascular Ultrasound Studies (2008) (0)
Multi-Device Applications of IVUS (1996) (0)
ApoA-1 Milano and Regression of Atherosclerosis—Reply (2004) (0)
21. Cardiac Ischemic Outcomes and Hospitalizations in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome Treated with Alogliptin or Placebo: New Insights from the EXAMINE Trial (13-OR) (2015) (0)
Quantitative Assessment of Aortic Regurgitation by Digital Subtraction Angiography (1988) (0)
Abstract 16913: Greater Coronary Atheroma Regression in Women Compared With Men: A Pooled Analysis of Serial Intravascular Ultrasonography Trials Utilizing High-intensity Statin Therapy (2015) (0)
Pioglitazone to reduce restenosis after bare-metal stent placement? (2009) (0)
Monitoring pharmaceutical interventions with ivus (2006) (0)
THE IMPACT OF BASELINE LEFT VENTRICULAR HYPERTROPHY ON CLINICAL OUTCOMES IN THE PRECISION TRIAL (2018) (0)
President's page: Cardiology without borders: embracing a healthy global association. (2004) (0)
Spontaneous of infarct stenosis after thrombolysis for acute myocardial infarction is associated with enhanced improvement in left ventricular wall motion (1990) (0)
THE RELATIONSHIP BETWEEN LIPOPROTEIN(A) AND PROGRESSION OF AORTIC STENOSIS IN A LARGE DYSLIPIDEMIC POPULATION (2019) (0)
Response to Letter Regarding Article, “Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients With Cardiogenic Shock After Acute Myocardial Infarct” (2008) (0)
Lipids and Guidelines -- "Let Me Be Simple-Minded Doctor!!" LDL-C Less Than 70 mg/dL and Pay Attention to HDL (2020) (0)
Comprar IVUS Made Easy (Book & DVD Set) | Steven E. Nissen | 9781841846835 | Informa Healthcare (2008) (0)
Abstract 18288: The Total-to-high Density Lipoprotein-cholesterol Ratio Associates With Coronary Atheroma Progression Rates and Reclassifies Disease Progression Across Populations With Varying Metabolic Risk (2015) (0)
Plaque (atheroma) morphology (2005) (0)
Erratum: Variability of area measurements obtained with different intravascular ultrasound catheter systems: Impact on clinical trials and a method for accurate calibration (Journal of the American Society of Echocardiography (2003) 16 (277-284)) (2005) (0)
Consequence of Overuse of Invasive Coronary Angiography—Reply (2011) (0)
Abstract 1558: Changes in Markers of Systemic Inflammation Predict Progression of Coronary Atherosclerosis in Patients With Abdominal Obesity (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Steven Evan Nissen?

Steven Evan Nissen is affiliated with the following schools:

Steven Evan Nissen's Academic­Influence.com Rankings

Why Is Steven Evan Nissen Influential?

Steven Evan Nissen's Published Works

Published Works

What Schools Are Affiliated With Steven Evan Nissen?

Steven Evan Nissen's AcademicInfluence.com Rankings